CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PM-CELL project aims to develop a rapid testing technology for characterizing cells used in biopharmaceutical production. By creating a unique 96-well micro-titre plate, the project seeks to streamline cell line selection, reducing costs and accelerating the development of effective therapeutics for human diseases.
Biopharmaceuticals have universal importance as effective therapeutics for many human diseases.
Biopharmaceutical production employs living cells as ‘production machinery’ with the selection of the producing cell line, a critical step for an efficient industrial process.
Current industry practices for cell selection are expensive and time-consuming.
The proposed PM-CELL project will result in the development of a rapid cellular characterisation testing technology.
The two-year project will resul…
TECHNO-PATH DISTRIBUTION
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, ROSKILDE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
United Kingdom, Sheffield
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ITTRALEE INSTITUID TEICNEOLAIOCHTA TRALI
Ireland, Tralee
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
Germany, KOENINGSWINTER
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
